Literature DB >> 17973823

Erythropoietic protoporphyria with eye complications.

Hiromi Tsuboi1, Kohzoh Yonemoto, Kensei Katsuoka.   

Abstract

We herein report a case of erythropoietic protoporphyria (EPP) complicated by a decrease in eyesight that occurred in a Japanese male. An ophthalmologist initially thought that the eyesight loss might be the result of idiopathic optic nerve atrophy due to a vascular obstruction in the fundus. There are no previous reports of EPP cases with eye complications. However, an eye abnormality has been reported in an animal model of protoporphyria after long-term, low-level exposure to blue light. As a result, in our case, it is therefore possible that a relationship may have existed between EPP and the onset of eye complications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17973823     DOI: 10.1111/j.1346-8138.2007.00386.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  7 in total

1.  Ferrochelatase regulates retinal neovascularization.

Authors:  Sardar Pasha Sheik Pran Babu; Darcy White; Timothy W Corson
Journal:  FASEB J       Date:  2020-07-27       Impact factor: 5.191

2.  Allogeneic corneoscleral limbus tissue transplantation for treatment of the necrosis in porphyria eye disease.

Authors:  Feng Yan; Yan Lu; Jie Yin; Feng Jiang; Zhen-Ping Huang
Journal:  Int J Ophthalmol       Date:  2014-08-18       Impact factor: 1.779

Review 3.  Liver disease and erythropoietic protoporphyria: a concise review.

Authors:  María José Casanova-González; María Trapero-Marugán; E Anthony Jones; Ricardo Moreno-Otero
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

4.  Ferrochelatase is a therapeutic target for ocular neovascularization.

Authors:  Halesha D Basavarajappa; Rania S Sulaiman; Xiaoping Qi; Trupti Shetty; Sardar Sheik Pran Babu; Kamakshi L Sishtla; Bit Lee; Judith Quigley; Sameerah Alkhairy; Christian M Briggs; Kamna Gupta; Buyun Tang; Mehdi Shadmand; Maria B Grant; Michael E Boulton; Seung-Yong Seo; Timothy W Corson
Journal:  EMBO Mol Med       Date:  2017-06       Impact factor: 12.137

Review 5.  Erythropoietic protoporphyria.

Authors:  Mario Lecha; Hervé Puy; Jean-Charles Deybach
Journal:  Orphanet J Rare Dis       Date:  2009-09-10       Impact factor: 4.123

6.  From the dermatologikum hamburg: quiz.

Authors:  Wendemagegn E Yeshanehe; Rajalakshmi Tirumalae; Almut Böer-Auer
Journal:  Dermatol Pract Concept       Date:  2012-10-31

7.  Retinal Phenotyping of Ferrochelatase Mutant Mice Reveals Protoporphyrin Accumulation and Reduced Neovascular Response.

Authors:  S P B Sardar Pasha; Trupti Shetty; Nathan A Lambert-Cheatham; Kamakshi Sishtla; Deepa Mathew; Anbukkarasi Muniyandi; Neeta Patwari; Ashay D Bhatwadekar; Timothy W Corson
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-02-01       Impact factor: 4.925

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.